UBP
IHE icon

Union Bancaire Privee’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Union Bancaire Privee’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.9K Hold
660
– – ﹤0.01% 433
2026
Q1 		$48.5K Hold
660
– – ﹤0.01% 445
2025
Q4 		$48K Hold
660
– – ﹤0.01% 443
2025
Q3 		$39.5K Hold
660
– – ﹤0.01% 430
2025
Q2 		$36.9K Hold
660
– – ﹤0.01% 430
2025
Q1 		$41.8K Hold
660
– – ﹤0.01% 441
2024
Q4 		$41.6K Buy
+660
New +$45.4K ﹤0.01% 499

Other funds holding IHE

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Union Bancaire Privee's IHE Position: Q2 2026 in Review

Union Bancaire Privee held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 660 shares worth $57.9K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Union Bancaire Privee first reported a position in IHE in Q4 2024 and has held it in 7 quarters since. 83 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Union Bancaire Privee held 660 shares of iShares US Pharmaceuticals ETF worth $57.9K as of Q2 2026.
  • Union Bancaire Privee left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #433 holding.
  • Union Bancaire Privee first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 7 quarters since.
  • 83 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.